
Neurology® Podcast
1,379 episodes — Page 3 of 28
Updates in Idiopathic Intracranial Hypertension
Dr. Jessica Ailani talks with Dr. Kathleen Digre about the recognition of symptoms, diagnostic imaging, treatment goals, and the importance of weight loss in managing IIH. Read the related article in JAMA. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
General vs Nongeneral Anesthesia for EVT in Patients With Large Core Strokes
Dr. Andy Southerland talks with Dr. Amrou Sarraj about the importance of understanding anesthesia's impact on patient outcomes, the implications for clinical practice, and future research directions in stroke treatment. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
WHO Launches New Technical Brief on Encephalitis
Dr. Kiran Thakur talks with Dr. Ava Easton about the World Health Organization's technical brief on encephalitis. Read the related article in The Lancet. Disclosures can be found at Neurology.org.
October 2025 Recall: Topics on Headache
The October 2025 Recall features four previously released episodes on topics related to headache. Dr. Jessica Ailani begins the episode with Dr. Kathleen Digre discussing the evolution of spontaneous intracranial hypotension. The episode transitions into a discussion with Dr. Tesha Monteith and Dr. Peter Goadsby about the classification of headaches. In the third episode, Dr. Jessica Ailani is joined by Dr. Francesca Puledda to discuss global recommendations for migraine. The replay concludes with Dr. Jessica Ailani's conversation with Dr. Richard B. Lipton on characterizing PRODROME in migraine. Podcast links: Spontaneous Intracranial Hypotension Updates Understanding the Classification of Headaches and the Science Behind Them Global Recommendations for Migraine Characterizing Prodrome in Migraine Article links: ICHD-4 Editorial International Headache Society Global Practice Recommendations Characterizing Prodrome (Premonitory Phase) in Migraine Disclosures can be found at Neurology.org.
2024 McDonald Criteria
Dr. Justin Abbatemarco talks with Dr. Daniel Ontaneda about the 2024 revisions of the McDonald criteria for diagnosing multiple sclerosis. Read the related article in The Lancet Neurology. Disclosures can be found at Neurology.org.
Overcoming Colonialism in Pathogen Genomics
Dr. Deanna Saylor talks with Dr. Senjuti Saha about colonialism in global health and the importance of pathogen genomics. Read the related article in The Lancet. Disclosures can be found at Neurology.org.
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 2
In the second part of this two-part series, Dr. Robert Holloway talks with Dr. Carolyn Rennels about legal and ethical considerations, the importance of interdisciplinary support, and the emotional impact on clinicians. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 1
In the first part of this two-part series, Dr. Robert Holloway talks with Dr. Carolyn Rennels about the background of the study, the definition and practice of MAID, and the main reasons that lead ALS patients to consider it. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.
Outcomes Following Acute Plasma Exchange for MOGAD
Dr. Justin Abbatemarco talks with Drs. John Chen and Smathorn Thakolwiboon about the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 2
In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about overcoming funding challenges, the importance of rigor and reputation, unmet needs in neurology, and leveraging AI in neurology research. Disclosures can be found at Neurology.org.
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 1
In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about recent advancements in neurology, emerging genomic therapies, the evolving understanding of long COVID, and current NINDS priorities. Disclosures can be found at Neurology.org.
Updates on All Things Myositis – Part 2
In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about treatment options, real-world case studies, and future directions in myositis research. Disclosures can be found at Neurology.org.
Updates on All Things Myositis – Part 1
In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about the different types of myositis, approaches to diagnosis, available diagnostic tools, and the evolving roles of MRI and biopsy in clinical practice. Disclosures can be found at Neurology.org.
September 2025 Recall: Topics on Epilepsy
The September 2025 Recall replay highlights four previously released episodes focused on epilepsy. Dr. Halley Alexander begins the series with Dr. Juan Luis Alcala-Zermeno, discussing outcomes of epilepsy surgery in patients with tonic-clonic seizures. She then speaks with Dr. Samuel W. Terman about patients' perceived seizure risk, seizure risk tolerance, and approaches to risk counseling. In the third episode, Dr. Alexander is joined by Dr. Vineet Punia to explore factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures. The replay concludes with Dr. Katie Krulisky's conversation with Dr. Leah Blank on how outpatient follow-up impacts readmission rates in older adults with epilepsy or seizures Podcast links: The Effect of Epilepsy Surgery on Tonic–Clonic Seizures Patient Perspectives on Antiseizure Medication Discontinuation Understanding Acute Symptomatic Seizures Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge Article links: The Effect of Epilepsy Surgery on Tonic–Clonic Seizures Patient Perspectives on Antiseizure Medication Discontinuation Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic Seizures Association of Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge in Medicare Beneficiaries Aged 65 and Older Disclosures can be found at Neurology.org.
GLP-1RA–Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies
Dr. Alex Menze talks with Dr. Christopher J. Klein about the clinical presentation, diagnosis, and management of diabetic lumbosacral radiculoplexus neuropathy and common fibular neuropathy in the context of GLP-1RA. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years
Dr. Jeff Ratliff talks with Dr. Valtteri Kaasinen about the clinical challenges of diagnosing Parkinson disease and how that diagnosis can evolve over time. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
FDG-PET-Based Machine Learning Framework to Support Neurologic Decision-Making
Dr. Trey Bateman talks with Dr. David T. Jones about how the StateViewer system leverages FDG-PET imaging and machine learning to improve diagnostic accuracy and clinical decision-making for Alzheimer disease and related disorders. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Optimal Timing of Anticoagulation After Ischemic Stroke and Atrial Fibrillation
Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation. Read the related article in The Lancet. Disclosures can be found at Neurology.org.
Implications for Diagnostic Criteria for Primary Lateral Sclerosis
Dr. Jeff Ratliff talks with Drs. Michael A. Van Es and Eva de Boer about the current diagnostic criteria for PLS, the role of genetic testing, and the clinical implications for patient management. Read the related article in Neurology®. Read the additional related article mentioned in this episode. Disclosures can be found at Neurology.org.
Long-Term Fatigue Following Transient Ischemic Attack
Dr. BJ Hicks talks with Drs. Birgitte Hede Ebbesen and Boris Modrau about the study's methodology, findings, and implications for clinical practice, emphasizing the need for better awareness and support for TIA patients. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease
Dr. Stacey Clardy talks with Casey R. Vanderlip about whether the accelerated decline in episodic memory among APOE4 carriers is due to increased Aβ deposition or heightened susceptibility to Aβ-related effects. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
The Effect of Epilepsy Surgery on Tonic–Clonic Seizures
Dr. Halley Alexander talks with Dr. Juan Luis Alcala-Zermeno about the outcomes of epilepsy surgery, specifically for patients with tonic-clonic seizures. Read the related article in Epilepsia. Read the additional related article in Epilepsia. Listen to the previous podcast episode mentioned in this episode. Disclosures can be found at Neurology.org.
August 2025 Recall: Topics on Dementia Diagnosis
The August 2025 recall spotlights four previously released episodes on topics related to dementia diagnosis. The episode begins with Dr. Amy Brodtmann discussing the complexities of diagnosing frontotemporal dementia in clinical practice. Next, Dr. Joseph Therriault delves into the use of plasma biomarkers in diagnosing Alzheimer disease. In the third episode, Dr. Trey Bateman discusses the growing significance of blood-based biomarkers in Alzheimer disease. The episode concludes with Dr. Gregg Day discussing the clinical implications of using plasma biomarkers in real-world patient care. Podcast links: Frontotemporal Dementia Differential Diagnosis in Clinical Practice Diagnosis of Alzheimer Disease Using Plasma Biomarkers Understanding Blood-Based Biomarkers in Alzheimer Disease Diagnostic Performance of Plasma Biomarkers in the Outpatient Memory Clinic Article links: Frontotemporal Dementia Differential Diagnosis in Clinical Practice Diagnosis of Alzheimer's Disease Using Plasma Biomarkers Adjusted to Clinical Probability Diagnostic Performance of Plasma p-tau217 and Aβ42/40 Biomarkers in the Outpatient Memory Clinic Disclosures can be found at Neurology.org.
Medical Student Perspectives on Stigma in FND
Dr. Kathryn Krulisky talks with Dr. Jordan Garris about educational gaps in understanding FND, the impact of stigma on patient care, and the importance of empathy in medical training. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org.
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis. Read the related article in The New England Journal of Medicine. Disclosures can be found at Neurology.org.
Clinical Approach to Dementia Risk in Patients with Parkinson Disease
Dr. Jason Crowell talks with Dr. Daniel Weintraub about clinical considerations and strategies for effective communication when addressing cognitive concerns in patients with Parkinson disease. Read the related article in Neurology®. Listen to the related podcast episode with Dr. Jeff Ratliff. Disclosures can be found at Neurology.org.
Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation
Dr. Dan Ackerman talks with Dr. James Ernest Siegler about the complexities of treating ESUS and emphasizes the importance of personalized treatment approaches based on individual patient factors. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Diagnostic Performance of Plasma Biomarkers in the Outpatient Memory Clinic
Dr. Trey Bateman talks with Dr. Gregg Day about the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care. Read the related article in Alzheimer's & Dementia. Disclosures can be found at Neurology.org.
Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease
Dr. Justin Abbatemarco talks with Dr. Eric L. Voorn about the efficacy of combined personalized home-based aerobic exercise and coaching on physical fitness in people with neuromuscular diseases, compared with usual care. Read the related article in Neurology®. Read the additional article that was referenced. Disclosures can be found at Neurology.org.
hES Cell-Derived Dopaminergic Neurons for Parkinson Disease
Dr. Jeff Ratliff talks with Dr. Claire Henchcliffe about the study's key findings while emphasizing the importance of educating patients about stem cell therapies and the ongoing advancements in this field. Read the related article in Nature. Disclosures can be found at Neurology.org.
Insights from the AAN's Resident Survey
Dr. Jason Crowell talks with Dr. Brian E. Emmert about the results from the 2022 AAN Resident Survey and explore areas for future improvement. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org.
July 2025 Recall: Practice of Neurology
The July 2025 recall features four episodes on systems and innovation in delivering neurologic care. The episode begins with Dr. Scott Friedenberg discussing challenges faced by neurologists in balancing financial productivity with optimal patient care. The episode leads into a conversation with Dr. Marisa Patryce McGinley discussing the utilization of telemedicine in neurology, particularly focusing on disparities in access among different demographic groups. The conversation transitions to Dr. Lidia Moura talking about the implications of large language models for neurologic care. The episode concludes with Dr. Ashish D. Patel discussing headache referrals and the implementation of a design thinking approach to improve access to headache care. Podcast links: Empowering Health Care Providers Disparities in Utilization of Outpatient Telemedicine for Neurologic Care Large Language Models for Quality and Efficiency of Neurologic Care Using Design Thinking to Understand the Reason for Headache Referrals Article links: Empowering Health Care Providers: A Collaborative Approach to Enhance Financial Performance and Productivity in Clinical Practice Disparities in Utilization of Outpatient Telemedicine for Neurologic Care Implications of Large Language Models for Quality and Efficiency of Neurologic Care: Emerging Issues in Neurology Using Design Thinking to Understand the Reason for Headache Referrals and Reduce Referral Rates Disclosures can be found at Neurology.org.
Prehospital Large-Vessel Occlusion Stroke Detection Scales
Dr. Dan Ackerman talks with Drs. Luuk Dekker and Jasper D. Daems about analyzing various anterior-circulation large-vessel occlusion (aLVO) stroke detection scales to determine which one is the most useful for prehospital triage. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
2025 European Stroke Organization Conference Highlights
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about several studies presented at the 2025 European Stroke Organization Conference (ESOC). Disclosures can be found at Neurology.org.
Role of Central Sensitization Syndrome in Patients With Autonomic Symptoms
Dr. Elizabeth Coon talks with Dr. Peter Novak about how central sensitization plays a role in the autonomic symptoms-sings dichotomy and the importance of addressing both conditions for optimal treatment. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies
Dr. Jeff Ratliff talks with Dr. Brin E. Freund about the evaluated incidence and risk factors for acute symptomatic seizures during CAR T-cell therapy. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Electronic Medical Record Alert to Prevent Iatrogenic Interventions in Patients With PNES
Dr. Halley Alexander talks with Dr. Serena Yin about the effectiveness of an electronic medical record best practice alert in preventing iatrogenic interventions for patients with a diagnosis of psychogenic nonepileptic seizures. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.
Patient Perspectives on Antiseizure Medication Discontinuation
Dr. Halley Alexander talks with Dr. Samuel W. Terman about patients' perceived seizure risk, seizure risk tolerance, and risk counseling techniques. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.
Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge
Dr. Katie Krulisky talks with Dr. Leah Blank about the impact of outpatient follow-up on readmission rates for older adults with epilepsy or seizures. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Seizure Action Plans in Pediatric Convulsive Status Epilepticus
Dr. Halley Alexander talks with Dr. Coral M. Stredny about the management of pediatric convulsive status epilepticus, focusing on the importance of seizure action plans and adherence to treatment protocols. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.
Clinical Reasoning Series: Intracerebral Hemorrhage and Tortuous Retinal Arterioles
Dr. Nadia Khalil talks with Dr. Jean Bouchart about the diagnostic approach to intracerebral hemorrhage, the causes of cerebral small vessel disease, and the interpretation of biomolecular tests. Read the related article in Neurology® Resident & Fellow Section. Disclosures can be found at Neurology.org.
June 2025 Recall: Topics on Stroke
The June 2025 replay features four previously released stroke episodes. It begins with Dr. Cheryl Bushnell discussing the 2024 primary stroke prevention guidelines, followed by an interview with Dr. Phillip Ferdinand on the connection between smoking and young cryptogenic stroke. Next, Dr. Aaron Shoskes addresses the vascular risk burden in young adults with stroke. The replay concludes with Dr. Seemant Chaturvedi's overview from the International Stroke Conference. Podcast links: 2024 Guideline for the Primary Prevention of Stroke Association of Smoking and Young Cryptogenic Ischemic Stroke Vascular Risk Factor Burden Among Young Adults with Ischemic Stroke Overview from the 2025 International Stroke Conference Article links: 2024 Guideline for the Primary Prevention of Stroke Association of Smoking and Young Cryptogenic Ischemic Stroke: A Case-Control Study Temporal Trends in Vascular Risk Factor Burden Among Young Adults With Ischemic Stroke: The Florida Stroke Registry Disclosures can be found at Neurology.org.
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis
Dr. Justin Abbatemarco talks with Drs. Sumanth Reddy and Jeffrey Gelfand about the complexities of small vessel predominant primary CNS vasculitis, clinical features, and the impact of early intensive immunosuppressive therapy on remission. Read the related article in Neurology® Neuroimmunology & Neuroinflammation. Disclosures can be found at Neurology.org.
Clinical Criteria for LATE
Dr. Greg Cooper talks with Dr. David A. Wolk about limbic predominant age-related TDP-43 encephalopathy (LATE) discussing its clinical features, diagnostic criteria, and the importance of recognizing this condition in the context of Alzheimer disease. Read the related article. Disclosures can be found at Neurology.org.
False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice
Dr. Stacey Clardy talks with Dr. Elia Sechi about the importance of understanding lab test results, the performance characteristics of assays, and the real-world implications of false positives in myasthenia gravis testing. Read the related article in Neurology®. Disclosures can be found at Neurology.org.
Transforming Neurology Education: Evaluating Teaching Incentive Programs
Dr. Roy E. Strowd talks with Dr. Susannah Cornes about a teaching incentive initiative designed to support and reward faculty in academic neurology. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org.
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals
Dr. Jeff Ratliff talks with Dr. Per Borghammer about the classification of Lewy body disease into brain-first and body-first subtypes, with a focus on the newly identified parasympathetic and sympathetic subtypes within the body-first category. Read the related article in Nature. Disclosures can be found at Neurology.org.
2025 AAN President's Award Recipient - Dr. Janis Miyasaki
Dr. Stacey Clardy talks with Dr. Janis Miyasaki about her journey into neurology, the integration of palliative care into neurologic practice, and the critical importance of patient-centered care. Read more about the 2025 AAN President's Award. Disclosures can be found at Neurology.org.
Spontaneous Intracranial Hypotension Updates
Dr. Jessica Ailani talks with Dr. Kathleen Digre about the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade. Disclosures can be found at Neurology.org.
Understanding Blood-Based Biomarkers in Alzheimer Disease
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease. Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026. Disclosures can be found at Neurology.org.